VIDEO: ‘Revolutionary’ treatment findings in early-stage lung cancer presented at ASCO

Ravi Salgia, MD, PhD, spoke with Healio about a study assessing the safety and efficacy of three cycles of neoadjuvant sintilimab plus platinum-doublet chemotherapy compared with two cycles in patients with early-stage lung cancer.
The findings were presented at ASCO Annual Meeting.
The study was “revolutionary for us to think about,” according to Salgia, medical oncologist, and professor and Arthur & Rosalie Kaplan Chair of the department of medical oncology and therapeutics research at City of Hope.

Ravi Salgia, MD, PhD, spoke with Healio about a study assessing the safety and efficacy of three cycles of neoadjuvant sintilimab plus platinum-doublet chemotherapy compared with two cycles in patients with early-stage lung cancer.
The findings were presented at ASCO Annual Meeting.
The study was “revolutionary for us to think about,” according to Salgia, medical oncologist, and professor and Arthur & Rosalie Kaplan Chair of the department of medical oncology and therapeutics research at City of Hope.